ACT Capital Management’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

ACT Capital Management’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$48K	Hold	8,500	–	–	0.07%	57
2022 Q2	$37K	Sell	8,500 -5,000	-37%	-$28.4K	0.05%	68
2022 Q1	$157K	Hold	13,500	–	–	0.17%	55
2021 Q4	$247K	Sell	13,500 -18,000	-57%	-$228K	0.18%	62
2021 Q3	$373K	Hold	31,500	–	–	0.19%	67
2021 Q2	$542K	Buy	+31,500	New	+$599K	0.28%	63

Other funds holding OYST

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

IFA

Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

TAM

Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACT Capital Management's OYST Position: Q3 2022 in Review

ACT Capital Management held its Oyster Point Pharma, Inc. Common Stock (OYST) position steady in Q3 2022 at 8,500 shares worth $48K. The position accounts for 0.07% of the portfolio, ranked #57.

ACT Capital Management first reported a position in OYST in Q2 2021 and has held it in 6 quarters since. The position peaked at $542K in Q2 2021. 60 funds tracked by Wall St. Rank hold OYST as of Q3 2022.

ACT Capital Management held 8,500 shares of Oyster Point Pharma, Inc. Common Stock worth $48K as of Q3 2022.
ACT Capital Management left its Oyster Point Pharma, Inc. Common Stock share count unchanged in Q3 2022.
Oyster Point Pharma, Inc. Common Stock made up 0.07% of ACT Capital Management's portfolio in Q3 2022, its #57 holding.
ACT Capital Management first reported a position in Oyster Point Pharma, Inc. Common Stock in Q2 2021 and has held it in 6 quarters since.
ACT Capital Management's Oyster Point Pharma, Inc. Common Stock position peaked at $542K in Q2 2021.
60 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q3 2022.

Based on ACT Capital Management's 13F filing for Q3 2022, filed 3 Nov 2022.